SHUMIN(SAM) LIU
Company: Shenzhen Enduring Biotech, Ltd.
Job title: Chief Executive Officer & Founder
Seminars:
PEG-Based Bispecific ADC: Better Tumor Penetration, Wider Therapeutic Window 4:30 pm
Assessing how it provides better tumor penetration Discussing how there were not any Fc related toxicities Exploring how it has a wider therapeutic windowRead more
day: Day Two